ACADIA PHARMACEUTICALS INC — Director's Dealing 2012

Jan 31, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2012-01-27

Reporting Person: Wells William McDowall (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-27	Stock Option (right to buy)	$1.60	A	15000	Acquired	2022-01-26	Common Stock (15000)	Direct

Footnotes

F1: 50% of the shares subject to the Stock Option vest and become exercisable on each of the first and second anniversary of the date of grant.